NCT03472066

Brief Summary

Treatment of precancerous lesions of the cervix by conization has been shown to increase the risk of premature delivery and premature rupture of the membranes. It has now been clearly established that the cervix is a growing organ during adolescence and early adulthood, It has been hypothetized that cervical conization during the growth phase reduced its growth potential, and induced shorter cervix during the upcoming pregnancy. No studies have been conducted investigating the age at which conization no longer had an impact on cervical size during pregnancy. This will help to identify the age at conisation below which patients will be identified as being at risk event, and thus offer increased monitoring and possibly prophylactic management by programmed strapping. We propose to measure the length of the cervix of pregnant patients who have benefited from conization, which is currently recommended by the Collège National des Gynécologues Obstetriciens Français .In addition, the investigators will use a control group consisting of non-con conical, parity-matched pregnant patients in whom a cervical measurement will also be performed.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
180

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2018

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 19, 2018

Completed
23 days until next milestone

First Submitted

Initial submission to the registry

March 14, 2018

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 21, 2018

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 19, 2019

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 19, 2019

Completed
Last Updated

March 21, 2018

Status Verified

March 1, 2018

Enrollment Period

1.4 years

First QC Date

March 14, 2018

Last Update Submit

March 14, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • The main objective is to study the correlation between the size of the cervix and the age at conization. age at conization

    Cervix length Measured during the second semester echography

    1 day

Study Arms (2)

a group of women who have been conized

Previous conization

Other: Previous conization

control group with asymptomatic patients

on routine second trim no previous conization

Other: no previous conization

Interventions

a group of women who have been conized,

a group of women who have been conized

group with asymptomatic patients on routine second trimester echography

control group with asymptomatic patients

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Including 84 evaluable patients for the primary endpoint would show a Pearson correlation of at least 0.3 between cervical size and age at conization. These calculations were carried out with a 5% risk of first bilateral species and 80% power. Taking into account the risk of incomplete data, we plan to include 90 patients. A control group of 90 patients will also be recruited.

You may qualify if:

  • Patient referred since January 2008 with pregnancy between 2008 and 2017
  • Pregnancy after conisation
  • Cervix size between 21 and 24 SA before any obstetric event
  • Control group: parity matching, asymptomatic patients

You may not qualify if:

  • Threat of late miscarriage,
  • Premature rupture of membranes before cervical echography,
  • Other pregnancies after study of 1st pregnancy after conisation,
  • No measurement of the conization specimen,
  • Lost to follow-up,
  • Age \<18
  • Twin Pregnancies
  • Patient under guardianship

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU Amiens-Picardie

Amiens, 80054, France

RECRUITING

Central Study Contacts

Julien CHEVREAU, Doctor

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 14, 2018

First Posted

March 21, 2018

Study Start

February 19, 2018

Primary Completion

July 19, 2019

Study Completion

August 19, 2019

Last Updated

March 21, 2018

Record last verified: 2018-03

Locations